<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05051189</url>
  </required_header>
  <id_info>
    <org_study_id>H50267</org_study_id>
    <nct_id>NCT05051189</nct_id>
  </id_info>
  <brief_title>Effect of Opioids on Central Control of Ventilation in Children With Obstructive Sleep Apnea</brief_title>
  <official_title>Effect of Opioids on Central Control of Ventilation in Children With Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Children OSA exhibit varying responses to opioids. It is unknown if the degree of&#xD;
      intermittent hypoxemia results in different opioid sensitivity&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ventilatory suppression in children following opioid administration is of obvious concern,&#xD;
      especially following routine surgical procedures (i.e. adenotonsillectomy). It is thought&#xD;
      that patients with obstructive sleep apnea (OSA) have increased sensitivity to opioids, and&#xD;
      especially in opioid na√Øve patients. Recent evidence in children suggests that patients with&#xD;
      moderate to severe OSA may not predispose patients to increased opioid sensitivity in the&#xD;
      form of respiratory depression when compared with patients that do not have OSA. However,&#xD;
      what is not known is wether the degree of hypoxemia experienced by patients effects the&#xD;
      opioid sensitivity. The aim of this study is to identify if children with known OSA&#xD;
      experience a difference in opioid induced respiratory depression based on the degree of&#xD;
      hypoxemia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2023</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2 groups will be identified-&#xD;
patients with sleep study O2 nadir &gt;85%&#xD;
patients with sleep study O2 nadir &lt;85%</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>The participant will be unaware of the arm</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory depression following opioids</measure>
    <time_frame>respiratory rate measured at each minute for 10 consecutive minutes following opioid administration</time_frame>
    <description>Identification of respiratory depression following fentanyl administration by recording the respiratory rate prior to and 10 minutes following fentanyl administration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory depression following opioids</measure>
    <time_frame>tidal volume measured at each minute for 10 consecutive minutes following opioid administration</time_frame>
    <description>Identification of respiratory depression following fentanyl administration by recording the tidal volume prior to and 10 minutes following fentanyl administration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory depression following opioids</measure>
    <time_frame>end tidal co2 measured at each minute for 10 consecutive minutes following opioid administration</time_frame>
    <description>Identification of respiratory depression following fentanyl administration by recording the end-tidal co2 prior to and 10 minutes following fentanyl administration</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>OSA</condition>
  <condition>Opioid</condition>
  <condition>Adenotonsillectomy</condition>
  <arm_group>
    <arm_group_label>Patients with sleep apnea having oxygen Saturation &gt;85%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Children with OSA having procedures requiring endotracheal intubation and an who will receive opioids for evaluation of respiratory changes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with sleep apnea having oxygen Saturation &lt;85%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Children without OSA having procedures requiring endotracheal intubation and an who will receive opioids for evaluation of respiratory changes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl Citrate</intervention_name>
    <description>Ventilatory response to fentanyl in patients with OSA Specifically: respiratory changes, CO2, RR, TV</description>
    <arm_group_label>Patients with sleep apnea having oxygen Saturation &lt;85%</arm_group_label>
    <arm_group_label>Patients with sleep apnea having oxygen Saturation &gt;85%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing tonsillectomy or adenotonsillectomy at Texas Childrens Hospital&#xD;
             main campus.&#xD;
&#xD;
          -  Ages 2 to up to 8 years&#xD;
&#xD;
          -  Preoperative sleep study demonstrating obstructive sleep apnea&#xD;
&#xD;
          -  Intubation without medication (e.g. no propofol prior to intubation)&#xD;
&#xD;
          -  Requirement for airway instrumentation: LMA or ETT&#xD;
&#xD;
          -  Inhalation induction of anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No obstructive sleep apnea&#xD;
&#xD;
          -  Central sleep apnea events &gt;1/hour&#xD;
&#xD;
          -  Use of premedication&#xD;
&#xD;
          -  IV induction of anesthesia&#xD;
&#xD;
          -  Syndromic patients&#xD;
&#xD;
          -  Known or suspected difficult airway&#xD;
&#xD;
          -  Allergy to Fentanyl&#xD;
&#xD;
          -  Known cardiovascular medications&#xD;
&#xD;
          -  Pulmonary hypertension&#xD;
&#xD;
          -  Total intravenous anesthesia required&#xD;
&#xD;
          -  Parental refusal&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Texas childrens Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Adler AC, Chandrakantan A, Nathanson BH, von Ungern-Sternberg BS. An assessment of opioids on respiratory depression in children with and without obstructive sleep apnea. Paediatr Anaesth. 2021 Sep;31(9):977-984. doi: 10.1111/pan.14228. Epub 2021 Jun 16.</citation>
    <PMID>34053151</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 2, 2021</study_first_submitted>
  <study_first_submitted_qc>September 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2021</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>Adam Adler MD, MS, FAAP</investigator_full_name>
    <investigator_title>Associate Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>De-identified data will be made available at the conclusion of the study upon reasonable written request to the PI</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

